Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 364.00
+0.50 (0.14%)
Feb 26, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €3.05 billion as of February 26, 2026. Its market cap has increased by 16.15% in one year.
Market Cap
3.05B
Enterprise Value
3.24B
Revenue
1.43B
Ranking
n/a
PE Ratio
22.92
Stock Price
€364.00
Market Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 3.05B, an increase of 1,301.96%. That is a compound annual growth rate of 8.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 3.05B | 1.82% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 109.77B |
| Sanofi | 97.56B |
| Sartorius Stedim Biotech | 17.78B |
| Ipsen | 13.09B |
| ABIVAX Société Anonyme | 8.25B |
| emeis Société anonyme | 2.26B |
| Clariane SE | 1.33B |
| Ramsay Générale de Santé | 1.20B |